PTX-022

· Palvella Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PTX-022, covering 2024-08-29 to 2024-08-29. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita [Phase 2, Phase 3]

See pricing